Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CPAY | ZS |
|---|---|---|
| Price | $391.10 | $200.16 |
| Change today | ▲ 0.64% | ▲ 0.37% |
| Market cap | $25.68B | $32.64B |
| Return, 3 months | – | – |
| Return, year to date | – | – |
| Return, 1 year | – | – |
| P/E (TTM) | 23.8 | -513.2 |
| P/B | 7.3 | 12.6 |
| P/E percentile vs own 5y | 78th | 26th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.5% | +24.9% |
| Net profit growth (YoY) | -11.4% | +80.8% |
| Gross margin | 79.0% | 76.8% |
| Operating margin | 40.5% | -3.6% |
| Net margin | 22.7% | -1.9% |
| Return on equity | 30.5% | -2.9% |
| Analyst target vs. price | +20.8% | +8.2% |
| Analyst buy share | 83% | 93% |
| RSI (14) | – | – |
| 30-day volatility | – | – |
| Max drawdown, 1 year | – | – |
| Trend read | – | – |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
